Centene Toekomstige groei

Future criteriumcontroles 1/6

Centene zal naar verwachting groeien in winst en omzet met respectievelijk 4.9% en 5.7% per jaar. De winst per aandeel zal naar verwachting groeien met 9.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.9% zijn.

Belangrijke informatie

4.9%

Groei van de winst

9.7%

Groei van de winst per aandeel

Healthcare winstgroei	20.8%
Inkomstengroei	5.7%
Toekomstig rendement op eigen vermogen	12.9%
Dekking van analisten	Good
Laatst bijgewerkt	06 Nov 2024

Recente toekomstige groei-updates

Recent updates

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Aug 02

Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching

Jun 22

A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price

Jun 04

Returns At Centene (NYSE:CNC) Appear To Be Weighed Down

May 14

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Apr 26

Centene Corporation Still An Opportunity With An A-Grade Valuation

Mar 31

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Mar 15

Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)

Feb 08

Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain

Jan 22

Is Centene (NYSE:CNC) Using Too Much Debt?

Jan 21

Centene: Overlooked Healthcare Giant

Nov 21

Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?

Nov 10

Centene: Solid Performance With Positive Outlook, But Limited Upside Potential

Oct 26

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Oct 22

Decoding Centene: Why I Think It's Undervalued

Oct 10

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Jul 31

Centene: Results Impress But Buyers Aren't Swarming Yet

Jul 27

Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet

Jul 12

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Apr 10

Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M

Feb 07

With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case

Jan 27

Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly

Dec 27

Centene: Once Again, With Quality, Now A 'Buy'

Dec 23

Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid

Dec 14

An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued

Nov 11

Winst- en omzetgroeiprognoses

NYSE:CNC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	172,141	3,430	4,070	5,299	13
12/31/2025	164,946	3,016	3,827	4,953	15
12/31/2024	161,276	3,110	1,888	2,524	11
9/30/2024	146,204	3,067	245	958	N/A
6/30/2024	144,064	2,823	2,261	2,957	N/A
3/31/2024	142,800	2,735	2,603	3,328	N/A
12/31/2023	141,266	2,702	7,254	8,053	N/A
9/30/2023	139,364	2,444	5,451	6,260	N/A
6/30/2023	138,111	2,713	7,651	8,571	N/A
3/31/2023	136,941	1,483	8,392	9,379	N/A
12/31/2022	135,999	1,202	5,257	6,261	N/A
9/30/2022	132,756	2,014	7,493	8,512	N/A
6/30/2022	129,228	1,860	5,985	6,982	N/A
3/31/2022	124,181	1,497	4,348	5,313	N/A
12/31/2021	118,573	1,347	3,295	4,205	N/A
9/30/2021	114,130	736	5,643	6,511	N/A
6/30/2021	111,284	720	2,863	3,757	N/A
3/31/2021	108,158	2,461	4,907	5,786	N/A
12/31/2020	104,280	1,808	4,634	5,503	N/A
9/30/2020	95,764	2,029	1,008	1,871	N/A
6/30/2020	86,523	1,556	1,918	2,724	N/A
3/31/2020	78,105	845	-804	-73	N/A
12/31/2019	70,807	1,321	753	1,483	N/A
9/30/2019	68,385	1,353	784	1,500	N/A
6/30/2019	65,507	1,277	1,498	2,147	N/A
3/31/2019	61,028	1,082	71	704	N/A
12/31/2018	56,688	900	559	1,234	N/A
9/30/2018	52,618	889	1,708	2,318	N/A
6/30/2018	48,655	1,075	N/A	1,867	N/A
3/31/2018	47,201	1,029	N/A	2,087	N/A
12/31/2017	45,810	828	N/A	1,489	N/A
9/30/2017	44,870	853	N/A	2,631	N/A
6/30/2017	43,646	796	N/A	3,016	N/A
3/31/2017	42,468	713	N/A	2,903	N/A
12/31/2016	37,693	562	N/A	1,851	N/A
9/30/2016	32,839	416	N/A	460	N/A
6/30/2016	28,062	360	N/A	40	N/A
3/31/2016	22,948	277	N/A	809	N/A
12/31/2015	21,292	356	N/A	658	N/A
9/30/2015	19,854	350	N/A	827	N/A
6/30/2015	18,548	339	N/A	1,206	N/A
3/31/2015	17,102	298	N/A	1,016	N/A
12/31/2014	15,689	268	N/A	1,223	N/A
9/30/2014	14,134	210	N/A	1,023	N/A
6/30/2014	12,700	179	N/A	713	N/A
3/31/2014	11,475	172	N/A	591	N/A
12/31/2013	10,544	161	N/A	382	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CNC ( 4.9% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van CNC ( 4.9% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.6% per jaar).

Hoge groeiwinsten: De winst van CNC zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van CNC ( 5.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van CNC ( 5.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CNC zal naar verwachting over 3 jaar laag zijn ( 12.9 %).

Centene Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Centene Corporation Provides Earnings Guidance for the Year 2024

Centene Corporation Updates Earnings Guidance for the Year 2024

Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024

Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Recent updates

Centene Corporation Provides Earnings Guidance for the Year 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024

Investor sentiment deteriorates as stock falls 16%

Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch

Centene Corporation to Report Q3, 2024 Results on Oct 25, 2024

Ambetter Health of Delaware Offers Health Insurance in Delaware in 2025

Ambetter from Coordinated Care Offers Health Insurance Statewide in Washington in 2025

Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?

Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy

Centene Corporation Announces the Election of Thomas R. Greco to Board of Directors

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Centene Corporation to Report Q2, 2024 Results on Jul 26, 2024

Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching

A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price

Returns At Centene (NYSE:CNC) Appear To Be Weighed Down

Centene Corporation Updates Earnings Guidance for the Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Centene Corporation Still An Opportunity With An A-Grade Valuation

Centene Corporation, Annual General Meeting, May 14, 2024

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024

Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain

Is Centene (NYSE:CNC) Using Too Much Debt?

Pure Health LLC completed the acquisition of Circle Health Group Limited from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Fiscal Year 2023 Results on Feb 06, 2024

Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024

Centene: Overlooked Healthcare Giant

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?

Centene: Solid Performance With Positive Outlook, But Limited Upside Potential

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation Names Wade Rakes as Chief Growth Officer

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Decoding Centene: Why I Think It's Undervalued

Centene Corporation to Report Q3, 2023 Results on Oct 24, 2023

Pure Health LLC agreed to acquire Circle Health Group Limited from Centene Corporation (NYSE:CNC) for an enterprise value of approximately $1.2 billion.

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Centene: Results Impress But Buyers Aren't Swarming Yet

Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet

Centene Corporation to Report Q2, 2023 Results on Jul 28, 2023

New Mountain Capital, L.L.C. acquired Apixio, Inc. from Centene Corporation.

Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer

Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer

New Mountain Capital, L.L.C. agreed to acquire Apixio, Inc. from Centene Corporation (NYSE : CNC).

Centene to Divest AI Platform Apixio

Independent Director notifies of intention to sell stock

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

CEO & Director recently bought US$1.9m worth of stock

Independent Director recently bought US$503k worth of stock

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings: EPS misses analyst expectations

Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M

With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case

Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly

Centene: Once Again, With Quality, Now A 'Buy'